Haloperidol attenuation of morphine abstinence: synergistic effect of acute lithium administration.
D000818:Animals; D004357:Drug Synergism; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D008094:Lithium / Q000494:pharmacology*; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009021:Morphine Dependence / Q000503:physiopathology*; D009270:Naloxone / Q000494:pharmacology; D051381:Rats; D013375:Substance Withdrawal Syndrome / Q000139:chemically induced / Q000503:physiopathology*
D008781:Methyltyrosines; D009270:Naloxone; D008094:Lithium; D006220:Haloperidol